QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.57 (-2.27%)
AMD   100.08 (-3.09%)
T   14.79 (+0.82%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-6.82%)
GE   107.77 (-0.94%)
DIS   79.54 (-2.61%)
AMC   7.86 (-3.56%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
OTCMKTS:WUXAY

WuXi AppTec (WUXAY) Stock Forecast, Price & News

$11.57
-0.25 (-2.12%)
(As of 10/3/2023 ET)
Compare
Today's Range
$11.52
▼
$11.78
50-Day Range
$8.86
▼
$11.92
52-Week Range
$7.38
▼
$14.10
Volume
86,679 shs
Average Volume
4,479 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest

WUXAY stock logo

About WuXi AppTec (OTCMKTS:WUXAY) Stock

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

WUXAY Price History

WUXAY Stock News Headlines

September 28, 2023 | americanbankingnews.com
Short Interest in WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Drops By 76.9%
July 19, 2023 | msn.com
WuXi Biologics Hatches New Baby With ADC Drug Unit IPO
October 3, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
July 10, 2023 | finance.yahoo.com
Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH Patients
May 26, 2023 | wsj.com
WuXi AppTec Co. Ltd. ADR
April 25, 2023 | marketwatch.com
WuXi AppTec Shares Slide After First-Quarter Softer Profit Growth
April 10, 2023 | marketwatch.com
Pharmaceutical Testing and Analytical Services Market Insights-Industry Changing Aspects, New Technologies and Forecast to 2030
April 7, 2023 | marketwatch.com
A Closer Look at the Patient Derived Xenograft or PDX Models Market (2023 to 2030)-Opportunities and Challenges
October 3, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
April 4, 2023 | marketwatch.com
Contract Research Organization (CRO) Market | 2023-2029
March 29, 2023 | marketwatch.com
Viral Clearance Service Market Size and Forecast till 2031
March 28, 2023 | marketwatch.com
Cell Banking Outsourcing Market: New Forecast Report 2029
March 20, 2023 | finance.yahoo.com
WuXi AppTec Reports Record Results in 2022
March 18, 2023 | seekingalpha.com
WUXAY WuXi AppTec Co., Ltd.
See More Headlines
Receive WUXAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:WUXAY
CUSIP
N/A
CIK
N/A
Web
www.wuxiapptec.com
Phone
862120663091
Fax
N/A
Employees
41,296
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2023 Cover
The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Ge Li Ph.D. (Age 56)
    Co-Founder, Chairman, Pres & CEO
    Comp: $5.78M
  • Dr. Minzhang Chen Ph.D. (Age 53)
    Co-CEO & Exec. Director
    Comp: $1.37M
  • Dr. Qing Yang Ph.D. (Age 53)
    Co-CEO & Exec. Director
    Comp: $1.18M
  • Dr. Edward Hu M.B.A. (Age 60)
    Vice Chairman & Global Chief Investment Officer
    Comp: $1.47M
  • Mr. Zhaohui Zhang (Age 53)
    COO of China, VP & Exec. Director
    Comp: $1.03M
  • Ms. Ming Shi (Age 48)
    Sr. VP & CFO
  • Mr. Kyler Lei
    IR Director
  • Dr. Howard Wu J.D.
    Sr. VP, Gen. Counsel & Global Head of HR
  • Dr. Shuhui Chen Ph.D. (Age 59)
    Exec. VP & Head of DDSU
  • Dr. Jingchao Dong Ph.D.
    Sr. VP & Head of RCS

Key Competitors

View All Competitors













WUXAY Stock - Frequently Asked Questions

Should I buy or sell WuXi AppTec stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for WuXi AppTec in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" WUXAY shares.
View WUXAY analyst ratings or view top-rated stocks.

How have WUXAY shares performed in 2023?

WuXi AppTec's stock was trading at $12.3570 at the start of the year. Since then, WUXAY stock has decreased by 4.3% and is now trading at $11.8250.
View the best growth stocks for 2023 here.

Are investors shorting WuXi AppTec?

WuXi AppTec saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 300 shares, a decrease of 76.9% from the August 31st total of 1,300 shares. Based on an average trading volume of 5,600 shares, the days-to-cover ratio is presently 0.1 days.
View WuXi AppTec's Short Interest.

What is WuXi AppTec's stock symbol?

WuXi AppTec trades on the OTCMKTS under the ticker symbol "WUXAY."

How do I buy shares of WuXi AppTec?

Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is WuXi AppTec's stock price today?

One share of WUXAY stock can currently be purchased for approximately $11.83.

How many employees does WuXi AppTec have?

The company employs 41,296 workers across the globe.

How can I contact WuXi AppTec?

WuXi AppTec's mailing address is 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China. The official website for the company is www.wuxiapptec.com. The company can be reached via phone at 862120663091.

This page (OTCMKTS:WUXAY) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -